AstraZeneca acquires EsoBiotec in $1 bn deal

AstraZeneca acquires EsoBiotec in $1 bn deal

18 Mar 2025

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of biotechnology company EsoBiotech in a $1 billion transaction

AstraZeneca starts global recall of its controversial Covid 19 vaccine

AstraZeneca starts global recall of its controversial Covid 19 vaccine

08 May 2024

Days after admitting that its Covid 19 vaccine could cause blood clot in some people, British-Swedish pharmaceutical company AstraZeneca

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.

Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!

Start your free subscription today!

Latest articles on AstraZeneca from Informachine

Saphnelo approved in the EU for subcutaneous self-administration as a new pre-filled pen for systemic lupus erythematosus

16 Dec 2025

Enhertu plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer

16 Dec 2025

AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH

04 Dec 2025

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

04 Dec 2025

Imfinzi approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers

26 Nov 2025

AstraZeneca plans $2 billion manufacturing investment in Maryland, supporting 2,600 jobs and catalysing economic growth

22 Nov 2025

Koselugo approved in the US for adults with neurofibromatosis type 1

20 Nov 2025

Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial

10 Nov 2025

9M and Q3 2025 results

07 Nov 2025

View details about the software product Informachine News Trackers